Ligand validation:4H03

EDO: 1,2-ETHANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Model completeness	Average occupancy
4H03_EDO_B_417	90%	82%	0.09	0.973	0.43	0.37	-	-	0	100%	1
4H03_EDO_B_407	88%	80%	0.075	0.949	0.41	0.43	-	-	0	100%	1
4H03_EDO_A_504	87%	83%	0.089	0.962	0.43	0.35	-	-	0	100%	1
4H03_EDO_A_509	85%	87%	0.088	0.954	0.48	0.21	-	-	0	100%	1
4H03_EDO_B_419	83%	86%	0.087	0.946	0.44	0.28	-	-	0	100%	1
4H03_EDO_A_505	81%	87%	0.11	0.963	0.45	0.24	-	-	0	100%	1
4H03_EDO_B_414	75%	88%	0.108	0.942	0.43	0.25	-	-	0	100%	1
4H03_EDO_B_422	63%	85%	0.152	0.947	0.45	0.29	-	-	0	100%	1
4H03_EDO_B_409	61%	87%	0.136	0.923	0.44	0.25	-	-	0	100%	1
4H03_EDO_A_513	56%	80%	0.144	0.917	0.43	0.42	-	-	0	100%	1
4H03_EDO_A_520	56%	87%	0.134	0.905	0.43	0.26	-	-	0	100%	1
4H03_EDO_A_517	54%	90%	0.106	0.871	0.46	0.14	-	-	0	100%	1
4H03_EDO_B_415	53%	86%	0.145	0.905	0.44	0.28	-	-	0	100%	1
4H03_EDO_A_503	48%	79%	0.145	0.889	0.43	0.44	-	-	0	100%	1
4H03_EDO_A_508	47%	88%	0.144	0.883	0.58	0.1	-	-	0	100%	1
4H03_EDO_A_515	45%	87%	0.139	0.871	0.41	0.28	-	-	0	100%	1
4H03_EDO_B_405	44%	79%	0.212	0.941	0.47	0.39	-	-	0	100%	1
4H03_EDO_A_518	42%	83%	0.157	0.874	0.43	0.36	-	-	0	100%	1
4H03_EDO_A_525	40%	87%	0.22	0.93	0.43	0.27	-	-	0	100%	1
4H03_EDO_B_412	37%	79%	0.168	0.865	0.4	0.47	-	-	2	100%	1
4H03_EDO_B_408	36%	79%	0.172	0.866	0.46	0.41	-	-	3	100%	1
4H03_EDO_A_514	32%	85%	0.188	0.861	0.47	0.27	-	-	0	100%	1
4H03_EDO_A_522	31%	78%	0.187	0.857	0.5	0.39	-	-	0	100%	1
4H03_EDO_A_510	30%	81%	0.14	0.802	0.43	0.4	-	-	0	100%	1
4H03_EDO_B_418	30%	85%	0.17	0.833	0.46	0.29	-	-	0	100%	1
4H03_EDO_A_512	23%	87%	0.231	0.851	0.41	0.28	-	-	0	100%	1
4H03_EDO_A_523	23%	83%	0.263	0.884	0.5	0.29	-	-	0	100%	1
4H03_EDO_A_516	23%	79%	0.203	0.822	0.44	0.43	-	-	0	100%	1
4H03_EDO_B_425	20%	71%	0.192	0.791	0.61	0.52	-	-	0	100%	1
4H03_EDO_B_410	18%	80%	0.315	0.905	0.36	0.47	-	-	2	100%	1
4H03_EDO_B_428	18%	81%	0.194	0.776	0.48	0.34	-	-	0	100%	1
4H03_EDO_B_404	16%	84%	0.22	0.788	0.6	0.18	-	-	1	100%	1
4H03_EDO_B_424	15%	87%	0.203	0.766	0.43	0.26	-	-	0	100%	1
4H03_EDO_A_511	15%	79%	0.174	0.732	0.46	0.41	-	-	0	100%	1
4H03_EDO_B_416	15%	86%	0.213	0.769	0.48	0.25	-	-	0	100%	1
4H03_EDO_B_411	13%	90%	0.22	0.764	0.45	0.18	-	-	2	100%	1
4H03_EDO_A_521	13%	87%	0.217	0.758	0.51	0.2	-	-	1	100%	1
4H03_EDO_B_427	12%	83%	0.315	0.848	0.46	0.32	-	-	0	100%	1
4H03_EDO_A_519	12%	90%	0.212	0.739	0.47	0.16	-	-	0	100%	1
4H03_EDO_B_413	12%	81%	0.238	0.765	0.47	0.36	-	-	3	100%	1
4H03_EDO_B_423	11%	84%	0.19	0.701	0.44	0.32	-	-	0	100%	1
4H03_EDO_B_421	10%	87%	0.218	0.726	0.45	0.25	-	-	0	100%	1
4H03_EDO_A_524	10%	84%	0.307	0.818	0.42	0.35	-	-	1	100%	1
4H03_EDO_A_507	10%	89%	0.189	0.686	0.44	0.22	-	-	1	100%	1
4H03_EDO_B_426	9%	77%	0.259	0.751	0.54	0.39	-	-	0	100%	1
4H03_EDO_B_420	5%	88%	0.328	0.743	0.46	0.22	-	-	0	100%	1
4H03_EDO_B_406	4%	90%	0.293	0.662	0.46	0.16	-	-	0	100%	1
4H03_EDO_A_506	3%	76%	0.269	0.622	0.42	0.53	-	-	0	100%	1
4H0V_EDO_B_406	87%	81%	0.082	0.955	0.4	0.42	-	-	0	100%	1
2ASP_EDO_A_700	73%	73%	0.093	0.918	0.69	0.35	-	-	0	100%	1
4H0Y_EDO_A_510	72%	86%	0.121	0.944	0.42	0.3	-	-	0	100%	1
4H0X_EDO_B_410	66%	79%	0.132	0.937	0.45	0.41	-	-	0	100%	1
2ASM_EDO_A_700	61%	74%	0.11	0.896	0.65	0.37	-	-	0	100%	1
6ANS_EDO_A_404	100%	89%	0.029	0.995	0.57	0.07	-	-	0	100%	1
4ITB_EDO_A_503	100%	88%	0.028	0.99	0.38	0.29	-	-	0	100%	1
4FQI_EDO_A_401	100%	85%	0.032	0.992	0.46	0.29	-	-	0	100%	1
4KXW_EDO_A_1003	100%	73%	0.033	0.993	0.64	0.4	-	-	0	100%	1
8JK3_EDO_A_304	100%	81%	0.033	0.992	0.22	0.58	-	-	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.

Prepare Data

Validate Data

Deposit Data

Help and Resources

4H03

EDO: 1,2-ETHANEDIOL